DVA · NYSE
DaVita (DVA) Stock Price & Fundamentals
DaVita (DVA) closed at $449.89 on Oct 9, 2026, down 1.32% from the previous close of $455.92.
Share price, past year
1Y −9.45%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $449.89 |
| Sep 30, 2026 | $474.53 |
| Aug 31, 2026 | $511.13 |
| Jul 31, 2026 | $490.53 |
| Jun 30, 2026 | $488.48 |
| May 29, 2026 | $475.05 |
| Apr 30, 2026 | $498.36 |
| Mar 31, 2026 | $507.52 |
| Feb 27, 2026 | $509.98 |
| Jan 30, 2026 | $476.70 |
| Dec 31, 2025 | $481.29 |
| Nov 28, 2025 | $499.65 |
| Oct 31, 2025 | $484.20 |
Key statistics
- Market cap
- $28.77B
- P/E (TTM)
- 39.1
- EPS (TTM)
- $11.51
- Revenue (TTM)
- $14.01B
- Net income (TTM)
- $847.48M
- Shares outstanding
- 64M
- Dividend yield
- —
- 52-week range
- $449.89 – $521.15
DaVita's market cap is $28.77B, based on a share price of $449.89 and 64M shares outstanding as of Jun 30, 2026.
Financials
DaVita reported revenue of $13.64B for fiscal 2025, up 6.46% from fiscal 2024.
DaVita earned net income of $746.80M in fiscal 2025, a net margin of 5.5%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $13.64B | +6.5% | $746.80M | 5.5% | $9.84 | $1.31B |
| FY2024ended Dec 31, 2024 | $12.82B | +5.6% | $936.34M | 7.3% | $10.73 | $1.47B |
| FY2023ended Dec 31, 2023 | $12.14B | +4.6% | $691.54M | 5.7% | $7.42 | $1.49B |
| FY2022ended Dec 31, 2022 | $11.61B | −0.1% | $560.40M | 4.8% | $5.85 | $961.14M |
| FY2021ended Dec 31, 2021 | $11.62B | +0.6% | $978.45M | 8.4% | $8.90 | $1.29B |
| FY2020ended Dec 31, 2020 | $11.55B | +1.4% | $773.64M | 6.7% | $6.31 | $1.30B |
| FY2019ended Dec 31, 2019 | $11.39B | −0.1% | $810.98M | 7.1% | $5.27 | $1.31B |
| FY2018ended Dec 31, 2018 | $11.40B | +4.9% | $159.39M | 1.4% | $0.92 | $784.50M |
| FY2017ended Dec 31, 2017 | $10.88B | +1.6% | $663.62M | 6.1% | $3.47 | $1.01B |
| FY2016ended Dec 31, 2016 | $10.71B | — | $879.87M | 8.2% | $4.29 | $1.14B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $3.55B | $265.40M | $4.02 |
| Q1 FY2026ended Mar 31, 2026 | $3.42B | $197.53M | $2.87 |
| Q4 FY2025ended Dec 31, 2025 | $3.62B | $234.22M | — |
| Q3 FY2025ended Sep 30, 2025 | $3.42B | $150.33M | $2.04 |
| Q2 FY2025ended Jun 30, 2025 | $3.38B | $199.34M | $2.58 |
| Q1 FY2025ended Mar 31, 2025 | $3.22B | $162.92M | $2.00 |
| Q4 FY2024ended Dec 31, 2024 | $3.29B | $259.33M | — |
| Q3 FY2024ended Sep 30, 2024 | $3.26B | $214.69M | $2.50 |
Company profile
- Name
- DaVita Inc.
- Ticker
- DVA
- Exchange
- NYSE
- Industry (SEC SIC)
- Services-Misc Health & Allied Services, NEC
- Headquarters
- 2000 16th Street, Denver, CO 80202
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000927066
Recent SEC filings
- Aug 4, 2026
- Aug 4, 2026
- Jun 8, 2026
- May 5, 2026
- May 5, 2026
- Feb 11, 2026
- Feb 2, 2026
- Nov 25, 2025
Frequently asked questions
What is DaVita's stock price?
DaVita (DVA) closed at $449.89 on Oct 9, 2026, down 1.32% from the previous close of $455.92.
What is DaVita's market cap?
DaVita's market cap is $28.77B, based on a share price of $449.89 and 64M shares outstanding as of Jun 30, 2026.
How much revenue does DaVita make?
DaVita reported revenue of $13.64B for fiscal 2025, up 6.46% from fiscal 2024.
What is DVA's P/E ratio?
DaVita's price-to-earnings ratio is 39.1, based on trailing twelve-month diluted EPS of $11.51.
Does DaVita pay a dividend?
DaVita's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from DaVita Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures